Select language:

Sputnik M adolescent vaccine efficacy reaches 93%

 / Главная / Russkiy Mir Foundation / News / Sputnik M adolescent vaccine efficacy reaches 93%

Sputnik M adolescent vaccine efficacy reaches 93%


11.01.2022

Photo credit: mos.ru / fragment (CC BY 4.0)

The effectiveness of the Russian Sputnik M vaccine reaches 93%, TASS reports. The anti-coronavirus drug is intended for adolescents between the ages of 12 and 17.

The first batches of the vaccine were released into civilian circulation at the end of December, 2021. The drug was introduced under the trade name Gam-COVID-Vac-M.

The coronavirus vaccine for adolescents was registered in Russia a month ago. Earlier, the head of the Gamaleya Center, Academician Alexander Gintsburg, said that Sputnik V was diluted with saline five times for adolescents and ten times for the younger group. According to him, these doses of the Russian drug will be effective and safe for children. 

The Ministry of Health assured that adolescents will be vaccinated only voluntarily with the consent of their parents or legal guardians.

Russkiy Mir

News by subject

Publications

Marco Maggi: ”Russian to the Bone" 20.01.2024
Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.